Last update 08 Mar 2025
Cytosite Biopharma, Inc.

Cytosite Biopharma, Inc.

Startups
|
Private Company|
2016|
Massachusetts, United States
|
< 10
|
www.cytositebiopharma.net

Overview

Tags

Neoplasms
Hemic and Lymphatic Diseases
Immune System Diseases
Peptide Conjugate Radionuclide
Diagnostic radiopharmaceuticals

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Neoplasms1
Immune System Diseases1
Top 5 Drug TypeCount
Peptide Conjugate Radionuclide1
Diagnostic radiopharmaceuticals1
Top 5 TargetCount
GRB(granzyme B)1

Related

1
Drugs associated with Cytosite Biopharma, Inc.
Gallium-68 NOTA hGZP
Target
GRB
Mechanism
GRB modulators
Active Org.
Cytosite Biopharma, Inc.Cytosite Biopharma, Inc.Startup
Originator Org.
Cytosite Biopharma, Inc.Cytosite Biopharma, Inc.Startup
Active Indication
Lymphoma [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Cytosite Biopharma, Inc.
NCT05285696
/ CompletedPhase 1
A Phase 1 Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.
NCT04169321
/ RecruitingPhase 1
First in Human Safety of [68Ga]-NOTA-hGZP- PET Imaging in Subjects Receiving Checkpoint Inhibitor Immunotherapy
100 Clinical Results associated with Cytosite Biopharma, Inc.
Login to view more data
0 Patents (Medical) associated with Cytosite Biopharma, Inc.
Login to view more data
100 Deals associated with Cytosite Biopharma, Inc.
Login to view more data
100 Translational Medicine associated with Cytosite Biopharma, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Gallium-68 NOTA hGZP
 ( GRB )		Solid tumor
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free